rdf:type |
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0039286,
umls-concept:C0220908,
umls-concept:C0227843,
umls-concept:C0231221,
umls-concept:C0232970,
umls-concept:C0332293,
umls-concept:C0439801,
umls-concept:C1512577,
umls-concept:C1522609,
umls-concept:C1554112
|
pubmed:issue |
3 Pt 1
|
pubmed:dateCreated |
2000-9-25
|
pubmed:abstractText |
Sonohysterography (SHG) has been proposed as a useful tool for the surveillance of the endometrium in patients receiving tamoxifen. This study aimed to assess the value of SHG in asymptomatic patients who would have been biopsy candidates because of abnormal transvaginal ultrasound (TVUS) results.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0090-8258
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2000 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10985880-Aged,
pubmed-meshheading:10985880-Aged, 80 and over,
pubmed-meshheading:10985880-Antineoplastic Agents, Hormonal,
pubmed-meshheading:10985880-Atrophy,
pubmed-meshheading:10985880-Breast Neoplasms,
pubmed-meshheading:10985880-Chemotherapy, Adjuvant,
pubmed-meshheading:10985880-Endometrial Neoplasms,
pubmed-meshheading:10985880-Endometrium,
pubmed-meshheading:10985880-Female,
pubmed-meshheading:10985880-Humans,
pubmed-meshheading:10985880-Hysterosalpingography,
pubmed-meshheading:10985880-Middle Aged,
pubmed-meshheading:10985880-Polyps,
pubmed-meshheading:10985880-Postmenopause,
pubmed-meshheading:10985880-Reproducibility of Results,
pubmed-meshheading:10985880-Risk Factors,
pubmed-meshheading:10985880-Tamoxifen
|
pubmed:year |
2000
|
pubmed:articleTitle |
Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
|
pubmed:affiliation |
Department of Medical Oncology, National Cancer Institute, Genoa, 16132, Italy. bertelli@hp380.ist.unige.it
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|